KNTE insider transaction filings
Kinnate Biopharma Inc. — 14 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-04-05. Screen KNTE transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for KNTE between 2026-06-13 and 2026-09-11. The table below lists the most recent filings on record.
Recent Form 4 filings — Kinnate Biopharma Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-04-05 | 4 | Farzan Nima — CHIEF EXECUTIVE OFFICER, Director | Disposition to issuer (D): 2,186 · Disposition to issuer (D): 1,281,642 (derivative) · Disposition to issuer (D): 437,413 (derivative) · Disposition to issuer (D): 275,000 (derivative) · Disposition to issuer (D): 400,000 (derivative) · Disposition to issuer (D): 750,000 (derivative) | EDGAR |
| 2024-04-05 | 4 | Krishnamohan Neha — CHIEF FINANCIAL OFFICER | Disposition to issuer (D): 64,087 · Disposition to issuer (D): 270,000 (derivative) · Disposition to issuer (D): 185,000 (derivative) · Disposition to issuer (D): 215,000 (derivative) | EDGAR |
| 2024-04-05 | 4 | Epperly Melissa B, — Director | Disposition to issuer (D): 60,751 (derivative) · Disposition to issuer (D): 20,250 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 20,250 (derivative) | EDGAR |
| 2024-04-05 | 4 | Rome Michael E — Director | Disposition to issuer (D): 40,501 (derivative) · Disposition to issuer (D): 20,250 (derivative) | EDGAR |
| 2024-04-05 | 4 | DeSimone Jill — Director | Disposition to issuer (D): 50,000 (derivative) | EDGAR |
| 2024-04-05 | 4 | Meltz Mark A — COO GENERAL COUNSEL SECRETARY | Disposition to issuer (D): 27,578 · Disposition to issuer (D): 384,508 (derivative) · Disposition to issuer (D): 121,503 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 135,000 (derivative) · Disposition to issuer (D): 215,000 (derivative) | EDGAR |
| 2024-04-05 | 4 | Sabzevari Helen — Director | Disposition to issuer (D): 40,501 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 20,250 (derivative) | EDGAR |
| 2024-04-05 | 4 | Foresite Capital Management IV, LLC — 10% owner Foresite Capital Fund IV, L.P. — 10% owner Foresite Capital Management V, LLC — 10% owner Foresite Capital Fund V, L.P. — 10% owner Foresite Capital Opportunity Management V, LLC — 10% owner Foresite Capital Opportunity Fund V, L.P. — 10% owner | Disposition to issuer (D): 9,671,643 · Disposition to issuer (D): 3,525,957 · Disposition to issuer (D): 520,711 | EDGAR |
| 2024-04-05 | 4 | Tananbaum James B. — Director, 10% owner | Disposition to issuer (D): 9,671,643 · Disposition to issuer (D): 3,525,957 · Disposition to issuer (D): 520,711 · Disposition to issuer (D): 40,501 (derivative) · Disposition to issuer (D): 20,250 (derivative) | EDGAR |
| 2024-04-05 | 4 | Smaldone Alsup Laurie — Director | Disposition to issuer (D): 60,751 (derivative) · Disposition to issuer (D): 20,250 (derivative) · Disposition to issuer (D): 20,250 (derivative) · Disposition to issuer (D): 25,000 (derivative) | EDGAR |
| 2024-04-05 | 4 | Flaherty Keith T. — Director | Disposition to issuer (D): 66,377 · Disposition to issuer (D): 32,064 (derivative) · Disposition to issuer (D): 56,112 (derivative) · Disposition to issuer (D): 11,391 (derivative) · Disposition to issuer (D): 20,250 (derivative) · Disposition to issuer (D): 20,250 (derivative) · +1 more | EDGAR |
| 2024-04-05 | 4 | GORDON CARL L — Director, 10% owner | Disposition to issuer (D): 1,368,339 · Disposition to issuer (D): 4,738,453 · Disposition to issuer (D): 1,368,338 · Disposition to issuer (D): 84,599 · Disposition to issuer (D): 450,000 · Disposition to issuer (D): 40,501 (derivative) · +2 more | EDGAR |
| 2024-04-05 | 4 | MITCHELL DEAN J — Director | Disposition to issuer (D): 121,503 (derivative) · Disposition to issuer (D): 20,250 (derivative) · Disposition to issuer (D): 20,250 (derivative) · Disposition to issuer (D): 25,000 (derivative) | EDGAR |
| 2024-04-05 | 4 | ORBIMED ADVISORS LLC — Director, 10% owner OrbiMed Capital GP VII LLC — Director, 10% owner OrbiMed Capital GP VIII LLC — Director, 10% owner OrbiMed Asia GP IV, L.P. — Director, 10% owner OrbiMed Advisors IV Ltd — Director, 10% owner OrbiMed Genesis GP LLC — Director, 10% owner ORBIMED CAPITAL LLC — Director, 10% owner | Disposition to issuer (D): 1,368,339 · Disposition to issuer (D): 4,738,453 · Disposition to issuer (D): 1,368,338 · Disposition to issuer (D): 84,599 · Disposition to issuer (D): 450,000 | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=KNTE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →